Riskpilot← Back to searchSign inGet full accessPHARMA MEDICO ApS
APSActiveCVR 28665741Hans Hartvig Seedorffs Stræde 12Manufacture of basic pharmaceutical products · NACE 2110Est. 200611 employeeswww.pharmamedico.com
Revenue 2024
DKK 21,6M
-18% vs 2023
EBITDA margin
61.8%
-27% vs 2023
Equity ratio
86.0%
Financial strength
Net profit 2024
DKK 8,6M
-39% vs 2023
| Revenue | DKK 21,6M | -18% |
| EBITDA | DKK 13,3M | -27% |
| Net profit | DKK 8,6M | -39% |
| Total assets | DKK 79,2M | +10% |
| Equity | DKK 68,1M | +14% |
| Employees | 11 | — |
Legal name
PHARMA MEDICO ApS
CVR number
28665741
Legal form
Anpartsselskab
NACE code
2110 · Manufacture of basic pharmaceutical products
Founded
4. juli 2006
Share capital
DKK 126.250
Employees
11 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktøren
Company purpose
Selskabets formål er at forske i, udvikle, producere og markedsføre fødevarer, kosmetik og farmaceutiske produkter samt anden dertil knyttet virksomhed efter ledelsens nærmere bestemmelse. Selskabet tilstræber at drive sin virksomhed på økonomisk, miljømæssigt og socialt ansvarlig vis.
Address
Hans Hartvig Seedorffs Stræde 12
Website
www.pharmamedico.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -221 | 685 | 4.976 | 7.517 | 6.566 | 8.693 | 15.059 | 13.726 | 10.687 | 19.238 | 30.301 | 26.193 | 21.584 |
| Staff expenses | -502 | -528 | -892 | -1.908 | -5.252 | -5.332 | -7.133 | -7.023 | -7.482 | -6.699 | -8.040 | -7.993 | -7.920 |
| EBITDA | -723 | 157 | 4.084 | 5.609 | 1.313 | 3.361 | 7.926 | 6.703 | 3.204 | 12.390 | 22.261 | 18.200 | 13.339 |
| Depreciation & amort. | -38 | -48 | -50 | -81 | -241 | -276 | -242 | -467 | -369 | -450 | -503 | -982 | -2.868 |
| EBIT | -761 | 109 | 4.035 | 5.528 | 1.073 | 3.085 | 7.684 | 6.236 | 2.835 | 11.941 | 21.758 | 17.217 | 10.471 |
| Net financials | -57 | -93 | -77 | -36 | -24 | -101 | -90 | 56 | -334 | 719 | -736 | 816 | 749 |
| Profit before tax | -818 | 15 | 3.957 | 5.492 | 1.049 | 2.984 | 7.594 | 6.291 | 2.501 | 12.660 | 21.023 | 18.033 | 11.220 |
| Tax | -179 | 14 | 982 | 1.370 | 161 | 722 | 1.775 | 1.531 | 533 | 2.277 | 4.585 | 4.014 | 2.611 |
| Net profit | -639 | 1 | 2.976 | 4.122 | 889 | 2.262 | 5.820 | 4.761 | 1.969 | 10.383 | 16.438 | 14.019 | 8.609 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 2.298 | 2.459 | 7.715 | 16.111 | 24.655 | 26.568 | 37.223 | 34.294 | 36.267 | 48.216 | 63.767 | 71.958 | 79.217 |
| Equity | 430 | 431 | 3.407 | 7.529 | 21.078 | 22.141 | 25.461 | 27.221 | 29.190 | 39.573 | 51.511 | 59.529 | 68.138 |
| Long-term debt | 0 | 0 | 0 | 0 | 306 | 193 | 132 | 110 | 319 | 0 | 0 | 0 | 0 |
| Short-term debt | 1.868 | 2.028 | 4.308 | 8.582 | 3.270 | 4.234 | 11.630 | 6.963 | 6.758 | 7.798 | 10.131 | 9.984 | 9.099 |
| Total debt | 1.868 | 2.028 | 4.308 | 8.582 | 3.577 | 4.427 | 11.762 | 7.073 | 7.077 | 7.798 | 10.131 | 9.984 | 9.099 |
EBITDA margin
61.8%
This company
15.8%
Market median
+291% vs market
20122024
Equity ratio
86.0%
This company
38.2%
Market median
+125% vs market
20122024
Return on equity
12.6%
This company
18.4%
Market median
+32% vs market
20122024
Net profit margin
39.9%
This company
8.1%
Market median
+393% vs market
20122024
Asset turnover
0.27×
This company
1.12×
Market median
-76% vs market
20122024
Debt / equity
0.16×
This company
0.62×
Market median
+74% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MC Management | Management | 2006 | — | — |
PM Founder | Founder | 2006 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 90.0% | 90.0% | 2021 | |
ANKERSTJERNE ApS | Company | 10.0% | 10.0% | 2009 |
URANIA HOLDING INVEST ApS | Company | 20.0% | 20.0% | 2006 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
PHARMA MEDICO ApS 
PHARMA MEDICO DENMARK ApSBoard members of PHARMA MEDICO ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Morten Christensen | Management | 0 companies |
| PHARMA MEDICO UK LIMITED | Founder | 0 companies |